HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arne Wrede Selected Research

Camptocormia

3/2015Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.
3/2012Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson's disease.
4/2010Camptocormia in idiopathic Parkinson's disease: a focal myopathy of the paravertebral muscles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arne Wrede Research Topics

Disease

5Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2017 - 05/2007
5Inflammation (Inflammations)
12/2015 - 05/2007
5Inclusion Body Myositis
09/2015 - 05/2007
3Glioblastoma (Glioblastoma Multiforme)
01/2022 - 12/2009
3Camptocormia
03/2015 - 04/2010
2Acquired CJD
10/2021 - 12/2009
2Dementia (Dementias)
01/2017 - 04/2012
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 05/2007
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 07/2008
2Muscular Dystrophies (Muscular Dystrophy)
09/2015 - 04/2012
2Myositis (Idiopathic Inflammatory Myopathies)
03/2012 - 05/2008
2Ischemia
02/2011 - 05/2006
2Scrapie
12/2009 - 05/2007
2Brain Ischemia (Cerebral Ischemia)
01/2008 - 05/2006
1Astrocytoma (Pilocytic Astrocytoma)
01/2022
1Sporadic Creutzfeldt-Jakob Disease
11/2021
1Fatal Familial Insomnia
10/2021
1Encephalitis (Encephalitis, Rasmussen)
11/2018
1Confusion (Bewilderment)
01/2017
1Parkinson Disease (Parkinson's Disease)
01/2017
1Seizures (Absence Seizure)
10/2015
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2015
1Neurologic Manifestations (Neurological Manifestations)
10/2015
1Multiple Sclerosis
10/2015
1Lymphopenia (Lymphocytopenia)
10/2015
1Progressive Multifocal Leukoencephalopathy
10/2015
1Ischemic Stroke
09/2015
1Muscular Diseases (Myopathy)
03/2013
1Glioma (Gliomas)
11/2012
1Neoplasms (Cancer)
11/2012
1Polymyositis
04/2012
1Dermatomyositis (Dermatopolymyositis)
04/2012
1Hypertrophy
03/2012
1Stroke (Strokes)
02/2011
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
02/2011
1Back Pain (Backache)
04/2010
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
12/2009
1Gliosis
12/2009
1Brain Diseases (Brain Disorder)
12/2009
1Disease Progression
05/2009
1Brain Injuries (Brain Injury)
05/2006

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2017 - 05/2006
6PrionsIBA
11/2021 - 05/2007
6Prion ProteinsIBA
09/2015 - 05/2006
4Amyloid (Amyloid Fibrils)IBA
03/2013 - 05/2007
3Messenger RNA (mRNA)IBA
09/2015 - 05/2008
2SteroidsIBA
11/2018 - 12/2015
2Protein AggregatesIBA
01/2017 - 08/2013
2Levodopa (L Dopa)FDA LinkGeneric
03/2015 - 04/2010
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2013 - 04/2012
2Amyloid beta-PeptidesIBA
05/2008 - 05/2007
1MethyltransferasesIBA
01/2022
1hydrogen sulfite (bisulfite)IBA
01/2022
1FumaratesIBA
10/2015
1Dimethyl FumarateIBA
10/2015
1AlarminsIBA
09/2015
1HMGB1 Protein (HMG1)IBA
09/2015
1Racemases and Epimerases (Epimerases and Racemases)IBA
03/2013
1N-acylmannosamine kinaseIBA
03/2013
1AcetylglucosamineIBA
03/2013
1Crystallins (Crystallin)IBA
03/2013
1Uridine Diphosphate (UDP)IBA
03/2013
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
03/2013
1AcidsIBA
11/2012
1AntibodiesIBA
11/2012
1PorphyrinsIBA
11/2012
1Bevacizumab (Avastin)FDA Link
11/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012
1Endopeptidase K (Proteinase K)IBA
05/2012
1Detergents (Detergent)IBA
05/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2012
1Indicators and Reagents (Reagents)IBA
04/2012
1Tyrosine (L-Tyrosine)FDA Link
04/2012
13-nitrotyrosineIBA
04/2012
1thioflavin TIBA
04/2012
1EnzymesIBA
03/2012
1Acid PhosphataseIBA
03/2012
1Dihydroxyphenylalanine (Dopa)IBA
04/2010
1Protons (Proton)IBA
12/2009
1Inositol (Myoinositol)IBA
12/2009
1Glutamine (L-Glutamine)FDA Link
12/2009
1Interleukin-1beta (Interleukin 1 beta)IBA
05/2008
1ChemokinesIBA
05/2008
1salicylhydroxamic acid (SHAM)IBA
05/2006
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2006
1Caspase 3 (Caspase-3)IBA
05/2006

Therapy/Procedure

1Therapeutics
10/2015
1Deep Brain Stimulation
03/2015
1Transcranial Direct Current Stimulation
02/2011